Effect of vitamin D treatment in chronic GVHD

Bone Marrow Transplantation

Volumn 46, Issue 10, 2011, Pages 1395-1397

  Silva, F ^a   Perez Simon J A ^a   Caballero Velazquez, T ^a   Sanchez Guijo F M ^a   Villanueva Gomez, F ^a   Vazquez, L ^a   Del Canizo C ^a   Caballero, D ^a   San Miguel, J ^a  

^a CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CALCIUM CARBONATE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; VITAMIN D;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; FEMALE; HODGKIN DISEASE; HUMAN; LETTER; MALE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OSTEOPENIA; OSTEOPOROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; VITAMIN D; YOUNG ADULT;

EID: 80053932269     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.317     Document Type: Letter

References (10)

1. Horwitz ME, Sullivan KM. Chronic graft versus host disease. Blood 2006; 20: 15-27. (Pubitemid 43106715)
2. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft versus host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956. (Pubitemid 41754712)
3. Pavletic S, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW et al. Measuring therapeutic response in chronic graftverus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response criteria working group report. Biol Blood Marrow Transplant 2006; 12: 252-266. (Pubitemid 43273710)
4. Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. Specific high affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 1983; 570: 1308-1310. (Pubitemid 14209439)
5. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983; 221: 1181-1183.
6. Lemire JM. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 1992; 49: 26-31.
7. Yee YK, Chintalacharuvu SR, Lu J, Nagpal S. Vitamin D receptor modulators for inflammation and cancer. Mini Rev Med Chem 2005; 5: 761-768.
8. Pakkala I, Taskinen E, Pakkala S, Raisanen-Sokolowski A. MC1288, a vitamin D analog, prevents acute graft-versus-host disease in rat bone marrow transplantation. Bone Marrow Transplant 2001; 27: 863-867. (Pubitemid 32496421)
9. Middleton PG, Cullup H, Dickinson AM, Norden J, Jackson GH, Taylor PRA et al. Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation. Bone Marrow Transplant 2002; 30: 223-228. (Pubitemid 35023594)
10. Rosenblatt J, Bissonnette A, Wu Z, Vasir B, Zarwan C, Keefe W et al. Immunomodulatory effects of vitamin D: implications for the treatment of graft-versus-host disease. Biol Blood Marrow Transplant 2009; 15 (supplement): 132